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Uncoupling proteinHaving worked for 55 years in the center and at the fringe of bioenergetics, my major research stations are
reviewed in the following wanderings: from microsomes to mitochondria, from NAD to CoQ, from reversed
electron transport to reversed oxidative phosphorylation, from mitochondrial hydrogen transfer to
phosphate transfer pathways, from endogenous nucleotides to mitochondrial compartmentation, from
transport to mechanism, from carrier to structure, from coupling by AAC to uncoupling by UCP, and from
speciﬁc to general transport laws. These wanderings are recalled with varying emphasis paid to the covered
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My research in the last 55 years has been imbedded in the
scientiﬁc developments of bioenergetics and biomembranes. Al-
though in the last decades my science was not at the core of
bioenergetics, in deference to the occasion, I feel that I have dealt with
bioenergetics most of my time. The term “Bioenergetics”was coined—
I believe—for the ﬁrst time in 1957 by Scent Györgi as the title of a
small monograph that included his pet, muscle physiology. It then
becamemore popular with Lehninger's little book “Bioenergetics,” ﬁrst
published in 1964. Although energetics are critical to a broad range of
biological activities as noted in particular by Otto Meyerhof, the term
bioenergetics became more conﬁned to the energy generation stored
in electrochemical potentials and in ATP rather than to the sink side of
energy utilization inmuscles ormembrane transport. In the following,
I will recount my wanderings in the bioenergetic–biomembrane
realms. Since this retrospective does not represent a review in the
proper sense, I have to excuse myself to the reader for restricting
citations only to those directly relevant to my scientiﬁc work.2. Microsomes, P450
In the early 1950s, isolated mitochondria started to become the
chief playground for bioenergeticists. Earlier, preparations consisting
of mitochondrial fragments had been used to study the respiratory
chain, the mysteries of fatty oxidation, etc. These preparations had
little capacity for oxidative phosphorylation (OxPhos). When I joined
Britton Chance in Philadelphia in late 1954 as a novice postdoc,
mitochondria were the hot targets for the special spectroscopic
instruments developed in the Johnson Foundation at the University of
Pennsylvania. These methods permitted to measure absorption
changes in turbid solutions and with high sensitivity, leading to the
classic papers by Chance and Williams [1–3] on respiratory control
and electron ﬂow through the respiratory components. Given a
choice, I did not enter the fray but chose a nonbioenergetic niche
provided by the discarded supernatants of mitochondrial prepara-
tions from liver, containing the “microsomes.” In this setting early in
1955, I stumbled over a large absorption band at 450 nm in
microsomes elicited by CO when NADH or dithionite was added [4].
Although I determined a heme content in the microsomes 2.5 times
that of the only known microsomal hemoprotein cytochrome b5, the
lack of α and β bands, which were typical for cytochromes, prevented
to associate P450 with the excess heme content and to call it a
cytochrome. These weak α and β bands were then found by Ryo Sato
and Tsuneo Omura under special conditions, after Ryo, who had
worked in Philadelphia in the same room as me, returned to Japan [5].
Thus, the P450 band could be rightfully named cytochrome P450.
Instead of picking up the barely covered diamonds on the way
at those days, kinetics of electron transport in microsomes were to
take the foreground of my work in the Pennsylvania Biophysics (JF)
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transport system than mitochondria since they were known to
contain only cytochrome b5 with NADH as reductant and a slow
unknown oxidase. Cytochrome c as a rapid oxidant of cytochrome b5.
served as a model electron acceptor for intercytochrome electron
transport. Thus, microsomes offered a system for studying the kinetics
of electron transfer using the available sensitive spectroscopic rapid
ﬂow methods.
3. Mitochondria
In my next station, I could no longer escape the enticing
bioenergetics embrace. In July of 1956, I joined Theodor Bücher in
Marburg, Germany, a former student of Otto Warburg, who had
recently found that the homogenates from locust muscle ﬂight
respired with glycerol-1- phosphate (G1P) at a rate exceeding the
highest rates with any substrate reported for other tissue homo-
genates [6]. My task was to isolate intact mitochondria from insect
muscles since the notion prevailed in the literature that insect
mitochondria exhibit no respiratory control [7,8]. Further, I was to
build a double-beam spectrophotometer, according to the principles
of Britton Chance's machine [9]. This was a challenge as the optics had
to be constructed with old but powerful quartz monochromators and
the electronics had to be assembled from scratch at the pretransistor
age. Eventually, both projects succeeded in 1957 and 1958: the
isolation of coupled ﬂight muscle mitochondria and a powerful high-
intensity double-beam spectrophotometer that braved its perfor-
mance tests with these mitochondria. [10]. The ﬂight muscle
mitochondria had the highest density of respiratory components
combined with an all powerful G1P-dehydrogenase that furnished a
unique playground for spectroscopic studies of the dynamics of
electron transport and coupled OxPhos. The cytochrome content was
higher than in any mammalian mitochondria [10–12].
4. Hydrogen transfer in mitochondria
4.1. Reversed hydrogen transfer
A strong absorption at 340 nm was generated by G1P in insect
ﬂight muscle mitochondria indicating a high reduction level of the
endogenous NAD, which was not reached with other substrates
(Fig. 1) [10,13]. Only in well-coupled mitochondria could this
phenomenon be demonstrated. The ﬁrst paradoxical ﬁnding was a
dramatic demonstration of reversed hydrogen transfer from a high
redox potential G1P to NAD. This interpretation of the strong signal atFig. 1. Reversed hydrogen transfer to NAD (DPN). Spectral absorption recording of a suspe
rapidly induces reduction of NAD, that is transiently reversed by ADP. Amytal, a weak inhibﬁrst caused disbelief until the analytical determination of NAD/NADH
in extracts from mitochondria vindicated an 80% reduction of the
endogenous NAD [14].
The reduction of NAD by succinate, as recorded at 340 nm in liver
mitochondria, had been previously interpreted as reversed hydrogen
transfer and was claimed to reach 100% reduction [3,15]. However,
analytical data showed that NAD was reduced to only 50% in liver
mitochondria [16]. Further, it had been objected that NAD was
reduced by malate produced from succinate [17,18] instead of by
reversed hydrogen transfer from succinate. With G1P as hydrogen
donor, this complication did not exist. Thus, with an analytically
determined reduction of NAD in insect ﬂight muscle mitochondria of
nearly 80% [14], the existence of reversed hydrogen (electron)
transfer was convincingly demonstrated. The signal was sensitive to
amytal (Fig. 1) and to activation of electron transport by ADP, Ca2+,
and DNP, indicating that only a high level of “intermediary” energy
could reverse electrons from high-redox potential substrates to NAD.
Were these 340-nm signals truly reﬂecting NADH? Could the
suggested intermediate NADH∼X [3] or NAD-X [19], that was thought
to stabilize the high NADH level, be isolated and identiﬁed? With
these questions discussed in the literature [3,14,18], I started a
program to directly determine NADH and NAD in extracts from
mitochondria, based on the stability of NADH in alkaline and of NAD in
acid extracts of mitochondria [16]. The enzymatic determination
permitted to separately measure the contents of NADH and NAD as
well as NADPH and NADP in the extracts, in contrast to the
spectrophotometric method. The high sensitivity of the double-
beam instrument was very helpful to accurately measure the small
amounts of endogenous NAD and NADH extracted frommitochondria.
4.2. Energy-linked transhydrogenation
A surprising result of the measurements in the extracts was that
liver mitochondria contained more NADPH+NADP than NADH
+NAD [16]. In further measurements of coupled mitochondria
isolated from skeletal and heart muscle, brain, and kidney [14], the
NADP(H) content was lower than that of NAD(H), especially inmuscle
mitochondria and nearly absent in the extremely active insect ﬂight
muscle mitochondria. Importantly, no evidence for NAD∼X or
NADH∼X was obtained; the sum NADH+NAD was constant,
independently of the energized or uncoupled state of mitochondria.
A further crucial ﬁnding was that, in liver mitochondria, the NADP
system was reduced to 95% as compared to the reduction of NAD to
only 50% (Fig. 2) [16]. By changing the “coupling states” of the
mitochondria, the reduction of NAD and NADP could be varied over ansion of insect ﬁght muscle mitochondria. Addition of Gly1-P (glycerol 1 phosphate)
itor of NADH dehýdrogenase reduces the effects (Fig. 6 in [10]).
Fig. 2. Energy-driven transhydrogenation from NADH to NADP. Analytical determina-
tions of reduced and oxidized NAD and NADP in rat liver mitochondria. The numbers
refer to different “energy states” of OxPhos varied by additions of ADP and substrates.
“1” refer to mitochondria respiring with endogenous subtrates, “2” on addition of ADP
initiating OxPhos with endogenous and “3” after addition of exogenous substrate
(hydroxybuyrate), “4” after conversion of ADP to ATP, and “5” after consumption of
oxygen. In the ordinate and abscissa, the log of the redox ratio is converted into
equivalent redox potential difference. The difference [RT/nF (log NADPH/NADP− log
NADH/NAD] ranges from−72 mV to−36 mV, corresponding to an energy-dependent
uplifting of hydrogen from NADH into NADPH. In the uncoupled state (+DNP), the
difference between the redox potential of the NADP and NAD systems is abolished
(Fig. 4 in [16]).
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(NADH/NAD) corresponding to a higher reduction level of the
NADP system [16]. The redox potential difference corresponded to
ENADP−ENAD≈−30 to−70 mV.When energy transfer was disturbed
by uncoupling or by inhibitors of electron transport, the redox ratios
of both systems became equal. With these results, we demonstrated
an energy-dependent transhydrogenation equilibrium in which
hydrogen is lifted from NADH into the more negative redox potential
NADP system. Direct evidence for the energy-linked transhydrogen-
ase was then obtained by Danielson and Ernster in submitochondrial
particles [20,21].4.3. The dual hydrogen pipeline concept
When comparing themitochondria of several tissues, the NAD(H)
content correlated well with the oxidative capacity measured by the
cyt a,a3 content [22], whereas the NADP(H) content related to the
reductive functions was represented by glutamate dehydrogenase
(GluDH) [23].This soluble dehydrogenase is exclusively located in
mitochondria. Although GluDH can use both NAD and NADP, the
correlation of the contents of GludH and NADP but not of NAD
indicates that GluDH is primarily associated with the NADP system.
The content of GluDH in liver mitochondria is very high, amounting
to more than 10% of soluble protein, whereas in heart mitochondria,
it is very low. As reviewed below, GluDH preferentially uses NADPH
in its main function of sequestering NH3 by producing glutamate
from NH3+ketoglutarate.
The concept of low hydrogen pressure in the NAD system and high
hydrogen pressure in the NADP system had ﬁrst been elaborated by
Theodor Bücher for the cytosol [24,25]. It was shown that the ratio
NADH/NAD ratio is in equilibrium with less negative redox potential
substrates such as the redox couples lactate/pyruvate and G1P/1-
phosphoglyceraldehyde and that the NADP system is linked to the
dehydrogenation of glucose-6-phosphate and isocitrate that operate
with a more negative redox potential. This enables the NADPH/NADP
to function as a hydrogen donor in reductive biosynthesis and the
NAD as a hydrogen acceptor in oxidative pathways.The dual hydrogen pipelines also exist inmitochondria but operate
with a more negative redox potential [24,26]. From malate, hydrogen
is fed into NAD with mitochondrial malate dehydrogenase but at a
higher malate/oxaolacetate ratio than in the cytosol. We proposed
that due to the exclusive location of hydroxybutyrate dehydrogenase
in mitochondria, in contrast to the dual location of malate dehydro-
genase, the hydroxybutyrate/acetoacetate ratio [24,26] can serve as
an exclusive measure of the mitochondrial NAD redox potential.
Further, the fact that the midpotential of this redox couple is more
negative and closer to the midpotential of NADH/NAD renders it a
suitable indicator of the redox potential of the NAD system [27,28].
The higher hydrogen pressure in the mitochondrial NADP system [16]
was shown to be primarily the result of the energy-dependent
transhydrogenation [20]; however, another potential source is
isocitrate.
4.4. The glycerol phosphate shuttle
In this context, as ﬁrst conceived by Theodor Bücher for the insect
ﬂight muscle [6], low-pressure hydrogen generated in glycolysis can
be transferred from the cytosolic high-redox potential of NADH/NAD
for oxidation into mitochondria via the “G1P shuttle.” G1P receives
hydrogen via cytosolic G1P dehydrogenase and carries it to the
mitochondrial G1P oxidase, a ﬂavoprotein and high-redox potential
dehydrogenase, which feeds hydrogen into the ubiquinone pool. This
pathway is realized to a widely varying degree in different tissues as
indicated by the large variations in the level of the G1P oxidase
activity [29]. As recognized soon after [30], the energy-driven malate–
aspartate shuttle can also channel hydrogen generated by glycolysis
into mitochondria by lifting hydrogen to the more negative
mitochondrial NAD system, thus bridging the intra- and extramito-
chondrial redox potential difference of the NAD systems (see reviews
[31,32]).
4.5. Intersubstrate hydrogen pathways
The striking hydrogen transfer reactions observed in conjunction
with reversed electron transfer led us to pursue some pathways of the
mitochondrial hydrogen transfer network. Up substrates were
interconverted in a millimolar range under conditions where the
mitochondria played only a catalytic role. To avoid oxidative drains,
the experiments were performed mostly under anaerobic conditions
with energy from added ATP [33]. Thus, for the ﬁrst time, a complete
reversal of OxPhos from ATP was achieved, after, earlier, a failure
to reverse electron transport by ATP was reported [15]. Initially, the
complete balance of the reversed electron transport from succinate to
acetoacetate driven by addition of ATP was measured [27]. The
demonstration that succinate could reduce substrate amounts of
acetoacetate to hydroxybutyrate in an approximate 1:1 stoichiometry
and that about equal amounts of ATP were consumed was the ﬁrst
proof of reversed hydrogen transfer on a substrate level. This
convinced hitherto incredulous observers [17,18] that reversal of
that reversed hydrogen transfer exists. The aerobic reduction of
acetoacetate in the presence of succinate was already interpreted [34]
as a reversed hydrogen transfer, but the complete substrate–energy
balance, convincing the skeptics, wasmeasured in our work [27]. After
subtracting various blank values, the energy coefﬁcients gave for the
anaerobic (or KCN inhibited) case ΔΔATP/ΔAcAc a reduction of 0.80
and for the aerobic case ΔΔO/ΔAcAc a reduction of 1.08 in support of
one energy-coupling step, driving the reversed hydrogen transfer. The
intriguing “superefﬁciency” of ATP/2Hb1 could later be explained by
the energy-dependent ADP/ATP exchange across the inner mem-
brane, where the “reversed” exchange ATP/ADP can generate energy
in addition to ATP hydrolysis amounting to 1/3 of the hydrolysis
energy [35]. Although succinate as a reductant for acetoacetate
may have limited physiological signiﬁcance, it is a model for the
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hydrogen transfer.
The reductive amination of ketoglutarate provided another
example of energy requirement in mitochondrial hydrogen transfer
reactions of great physiological importance since it involved the
sequestration of NH3 for the formation of amino acids and of urea
(Fig. 3) [36,37]. The substrate interconversions, their kinetics, and
thermodynamics were studied in great detail. Total reaction without
respiration was as follows: malate+NH3=aspartate, and under
respiration: succinate+NH3+ “O”=aspartate+H2O. Energy was
supplied from ATP and from electron transport. Intermediary
products were ketoglutarate, glutamate, and oxaloacetate. The
kinetics and the balance of the involved metabolites were studied in
detail. Two steps of the reaction sequence are energy-dependent: the
hydrogen transfer from succinate to NAD and the transhydrogenation
to NADP (Fig. 3). A third energy-dependent step was the release of
aspartate from mitochondria [38], later explained by the energy-
dependent Glu/Asp exchange across the inner membrane [39].
Novel redox potential nomograms were introduced that revealing
[37,38] that without energy the reductive amination of ketoglutarate
(+NH3) by glutamate dehydrogenase (GluDH) is in near equilibrium
via transamination with the corresponding oxaloacetate (+NH3)/
aspartate pair, whereas the malate/oxaloacetate couple differs by a
more negative redox potential of nearly −30 mV. With ATP, the
potentials are shifted in opposite direction: the reductive transami-
nation system to a more negative potential and the malate/
oxaloacetate to more positive potential, reﬂecting the ATP-driven
transhydrogenation from NADH to NADPH. Interestingly, isocitrate
and hydroxybutyrate were less efﬁcient hydrogen donors than
succinate or malate, indicating compartmentation of the mitochon-
drial NAD, and a preference of the reductive mode of mitochondrial
NAD for energy-backed reversed hydrogen transfer.
5. Reversal of oxidative phosphorylation
Reversed hydrogen transfer from succinate and G1P to NAD was
conﬁned to the ﬁrst coupling site of the respiratory chain. In
subsequent work, we were able to demonstrate reversed electron
transfer along the whole respiratory chain including cytochrome a,a3
[33,40]. In particular, under conditions where respiration was
partially or fully inhibited and providing NADH and NADPH oxidizing
substrates, upon addition of ATP all respiratory components becameFig. 3. Intersubstrate pathways of energy-linked hydrogen transfer in mitochondria.
Hydrogen from succinate, via energy-driven reversed hydrogen transfer, or from
malate is fed into the NADH/NAD pool. FromNADH, hydrogen is transferred via energy-
driven transhydrogenase into the NADPH/NADP pool, and from there via the NADPH-
linked GluDH into the reductive amination of ketoglutarate+NH3 (scheme 1 in [37]).increasingly oxidized to various degrees, fromNAD to cytochrome a,a3
(Fig. 4) [40] . Most efﬁcient were ketoglutarate+NH3 and oxaloac-
etate as traps for reversed electron transfer. Herewith a complete
reversal of OxPhos from ATP including the ATP synthase and
intermediate energy-transmitting stages was demonstrated.
The oxidizing effect of ATP could be reversed by ADP in the
presence of Pi, showing that the phosphorylation potential deﬁned by
the ATP/ADP·Pi ratio controls the electron transport. By systemati-
cally titrating the redox state of cytochrome c with ATP, ADP, and Pi in
the presence of given concentrations of ATP, ADP, or Pi, the energy to
maintain cyt c at the redox midpoint, was measured to ΔG=
−12.5 kcal [41]. This energy corresponds to a downshift of two
electrons by –280 mV.
Physiologically more important but less drastic were the effects of
ATP under aerobic conditions [33,42]. Until then, only ADP and Pi
were considered to control respiration and the inability of ATP to
control respiration was reported [15]. We found that ATP counter-
acted stimulation by ADP. In parallel, the redox states of the
respiratory components were altered: cytochromes c and a,a3 were
more oxidized and cytochrome b, ﬂavoprotein, and NAD were more
reduced (see also [43]). This “crossover” could be shifted upward, by
limiting cyt oxidase with azide, or downward, by limiting the
hydrogen inﬂow from substrates. Titrations with ATP versus ADP
and Pi yielded an “equilibrium” potential of ΔG=−14.8 kcal
[41,44,45], which is distinctly greater than that measured under
anaerobic conditions, The potential shows that the aerobic conditions
exert additional energy on ATP of aboutΔΔG=−2.3 kcal. This ﬁnding
anticipated that the energy of external ATP is uplifted by the
membrane potential-driven ADP/ATP exchange, as discussed below.
6. The ubiquinone (coenzyme Q) pool
Ubiquinone (UQ) proved to be a fertile ground for my penchant to
adapt or construct special instrumentation for solving a problem. After
the discovery of ubiquinone (UQ) for quite some time, its postulated
role in the respiratory chain could not unequivocally be demonstrated.
Reconstitution of UQ-depleted respiratory preparations was notFig. 4. Reversal of oxidative phosphorylation. Recording of the oxidoreduction of
cytochrome c in rat liver mitochondria. The respiration is inhibited by KCN. After
addition of oxaloacetate (OA), ATP induces increasing oxidation of cytochrome c, that is
reversed by uncoupling with dinitrophenol (DNP) (Fig. 11 in [40]).
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spectrophotometric recording and extractions of reduced andoxidized
UQ [47,48], that UQ is not on themain path of electron transport.With
a dual-beam quartz spectrophotometer and speciﬁc uv ﬁlters to
selectively detect the UQ signal in mitochondria, UQ absorption
changes could be clearly separated [49,50] from changes of other
components, such as NAD or cyt c, that had interfered in other
laboratories. Further, following our effort to determine the true
reduction level of NAD and NADP in extracts, a methodwas developed
to extract UQ directly from mitochondria in such a manner that the
instantaneous redox level would be retained in the extracts [49,50].
This seemed not to be the case in previous works, e.g., by Hateﬁ et al.
[51,52] where the redox state UQ was altered due to slow quenching.
Equipment was developed to extract multiple samples from the
mitochondrial suspension during the recording of UQ absorption [53].
The absorption changes and analytical redox values of UQ correlated
under a wide variety of respiratory conditions. It was shown that, in
all steady states of electron transport, the redox level of UQ ﬁtted well
with the other components of the respiratory chain when placed
between ﬂavin and cytochrome b. In fact, the redox level of UQ proved
to be most reliable in reﬂecting the reducing pressure from a wide
variety of substrates and its control by the energy transfer system of
OxPhos [53]. These results not only vindicated that UQ is a competent
member of the respiratory chain but also established the “pool”
function of UQ in collecting hydrogen from various dehydrogenases at
the ﬂavoprotein level [50,54,55]. With these analytical methods, we
determined the yet unknown standard redox potential of UQ in the
mitochondria t E′m=50 mV by equilibrating UQ with various
succinate/fumarate ratios [56].
The stoichiometric excess of UQ, which ranges from 4 to 7 over the
cytochrome complexes in mitochondria from various sources, was
conceived to create a hydrogen carrier pool similar to NAD [54,55].
Whereas NAD is located in the aqueous matrix space, UQ is bound to
the inner membrane, where it collects hydrogen from the different
membrane-bound dehydrogenases. We stressed that UQ is not ﬁxed
and that it is ready to communicate via a highly efﬁcient two-
dimensional diffusion with the more immobile dehydrogenases and
cytochrome complexes. There was no bypass around UQ for hydrogen
from the wide variety of dehydrogenases, as shown even for external
NADH dehydrogenases in yeast and neurospora [57,58]. Moreover,
the cyanide-insensitive oxidase in neurospora mutants, also present
in plant mitochondria, was shown [57] to branch off from the UQ pool
and not from cytochrome b as hitherto reported. Thus, this oxidase
competed with the normal cyanide-sensitive respiration for the
reduced UQ.
Previously, the reduction rates of UQ had been judged to be too
slow to function on the main path of the respiratory chain. With new
equipment, the moving mixing chamber [59] and the quench ﬂow
apparatus [60], the rates of the redox changes of UQ were followed
upon addition of substrates, ADP, uncouplers, etc. Achim Kröger
succeeded to quench and analytically determine (down to 2 ms) the
reduction or oxidation rate of UQ. Both techniques yielded rates
commensurate with those of the cytochromes [55,61], thus providing
direct evidence that UQ is fully engaged in the respiratory chain [55].
By reconstituting UQ-depleted submitochondrial particles, the pool
size of UQ was varied, and by measuring the reduction and oxidation
rates of UQ, a quantitative model for the inﬂux and efﬂux of hydrogen
to and from the UQ pool was obtained [60]. The homogeneity of the
kinetic response of UQ demonstrated that all UQ present participated
in the hydrogen transfer.
A further spin-off from the UQ pool concept was the interpretation
of the well-known sigmoidal inhibition [62,63] of electron transport
by high-afﬁnity inhibitors such as antimycin A (AA) [60]. In
submitochondrial particle respiration, the redox steady state and
the oxidation rate of UQ were titrated with AA. Interestingly, the
redox level of UQ responded linearly to titration with AA, whereasrespiration and the oxidation rate of UQ had a nonlinear response. The
nonlinearity depended on the ratio of inﬂow to outﬂow of UQ and
disappeared when the inﬂow was larger than the outﬂow rate. All
these results could be ﬁtted into a quantitative model that predicted
this behavior by assuming that electrons ﬂow into a common UQ pool,
which distributes electrons to the cytochrome complexes. When part
of the cytochrome chains is “titrated” with AA, UQ can redistribute
electrons (hydrogen) to the free cytochrome chains that may have
enough capacity to handle the additional ﬂow without a noticeable
overall decrease. An allosteric model of AA inhibition [64] was thus
dismissed.
Our interest also turned to quinones in gram-positive bacteria
containing menaquinone (MQ) instead of or together with UQ. Due to
its naphthoquinone (vs. benzoquinone) head group, MQ has a 150mV
more negative redox potential (b−100 mV) than UQ. Correspond-
ingly, in Proteus rettgeri, MQ was found to operate as a hydrogen
acceptor for the low-potential formate and to mediate hydrogen to
fumarate reductase [65]. Shuttling between the two dehydrogenases,
UQ reoxidizes the succinate produced and feeds into the respiratory
cytochromes. In this context, we speculated about the evolution of
quinone function, suggesting that before the advent of oxygen early
anaerobes had no quinones [54]. The ﬁrst electron transport systems
with electron acceptors such as sulphate or fumarate used low-redox
potential MQ. With increasing atmospheric oxygen pressure, UQ
emerged for supplying hydrogen into higher-potential cytochrome
chains that ultimately fed into high-redox potential acceptors such as
nitrate and oxygen.
7. Transmembrane organization of the respiratory chain
In the leading article of the monograph “Biological Oxidations,”
edited by Thomas Singer in 1968, I summarized and evaluated
knowledge on the respiratory chain composition and function [66].
According to my measurements and the literature, in the paradigm of
bovine heart mitochondria, the stoichiometric composition of the
respiratory chain was pictured to consist of equal amounts of cyt b, c,
and a, and cyt c1 at half that amount. Based on the FMN content, the
NADH dehydrogenase level was 7 times lower than that of cyt a.
Calculating the inner membrane surface in mitochondria, the spatial
distribution of the components was projected on a unit area of
250×250 Å containing one cyt b and cyt a complex. These were
connected by diffusible UQ to the stoichiometrically lower
dehydrogenases.
Given our interest in membrane permeability, we wished to
determine from which membranes side the respiratory components
are accessible. NADH dehydrogenase faces the matrix since NAD was
shown not to penetrate into the matrix. Within our program of
localizing enzymes by differential extractions, we found that
cytochrome c must be located on the outer side of the inner
membrane similar to creatine kinase [67]. In our laboratory,
Ferdinando Palmieri showed [68] that azide inhibited respiration
only after it had been taken up into the matrix. The sensitivity to azide
was strongly increased when azide was pumped into the mitochon-
dria and was decreased by uncouplers. Conversely, the sensitivity to
azide wasmuch lower in submitochondrial particles. It was concluded
that the azide and identical oxygen-binding site in cyt a3 face the
matrix side, whereas the electron acceptor site for cytochrome c
would be located on the outer surface. We inferred that these ﬁndings
demonstrate a transmembrane electron transport in cyt a,a3.
Further, we introduced the electron acceptor ferricyanide (FeCN)
as a probe for membrane side localization after making sure that
labeled 53FeCN does not penetrate the membrane [69]. FeCN readily
intercepted electrons from cyt c inmitochondria in agreement with its
location outside. Electron transport from succinate to FeCN was
blocked by AA, showing that succinate-DH is located inside. In
contrast, in broken mitochondria, FeCN reduction becomes AA-
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Surprisingly, with G1P as a substrate, FeCN reduction was insensitive
to AA both in intact and in broken mitochondria, indicating that FeCN
interacts directly from the outside with the mitochondrial G1P-DH,
which is now classiﬁed as the only dehydrogenase located on the
outer side in mammalian mitochondria. However, in mitochondria
from yeast and neurospora, external NADH and NADPH were oxidized
as well [70]. This oxidation is also insensitive to AA, indicating an
external acceptor site of the NADH/NADPH-DH in contrast to the AA-
sensitive FeCN reduction by electron ﬂow from internal NADH-DH
[58,71]. UQ was shown to be the common acceptor for hydrogen from
both externally and internally facing membrane-bound dehydro-
genases. These early results on the membrane topology of respiratory
components anticipated the postulates of the chemiosmotic theory of
speciﬁc transmembrane localization of the electron-transferring
groups in the respiratory chain.
8. Phosphoryl transfer pathways in mitochondria
Mitochondria were earlier known to contain high amounts of
adenine nucleotides besides pyridine nucleotides. Speculation arose
as whether these nucleotides are free or bound and whether they are
bypassed by OxPhos. With new nanomolar high-resolution anion
exchange techniques developed by Theodor Bücher and by Heinrich
Schnitger [72], who was also the inventor of the universal micropi-
pette [73], an inventory. The corresponding FeCN reduction of
phosphate-containing metabolites in mitochondria was obtained
[74]. Besides adenine nucleotides, guanine, uridine, and cytidine
nucleotides were also detected. The participation of these nucleotides
in OxPhoswasmeasured by following the incorporation of 32Pi [75]. In
different experimental approaches, it was shown that 32Pi incorpo-
rated ﬁrst into ATP converted from endogenous ADP and AMP and
subsequently into ATP generated from exogenous ADP. Segregation of
OxPhos from the intra- and extramitochondrial adenine nucleotide
pools was accomplished by inhibiting the exchangewith atractyloside
[76] or by low temperature [77]. These ﬁndings eliminated the
previous uncertainty of whether the intramitochondrial pool followed
by the subsequent transport step is on the main path of OxPhos.
Nonetheless, the idea persisted that ATP synthesis takes place in
microcompartments at the ATP synthase bypassing the endogenous
pool [78,79]. This question is intertwined with the ADP/ATP transport
through the inner membrane to be discussed below and was
scrutinized by sophisticated simultaneous kinetic transport and ATP
synthesis experiments [80,81] to demonstrate that exogenous ADP
has to enter the endogenous pool before being phosphorylated and
also that synthesized ATP must ﬁrst mix with the endogenous pool
before being exported.
In this context, the mitochondrial compartmentation of other
phosphate transfer reactions was elucidated. Substrate-level phos-
phorylation by the succinyl CoA thiokinasewas shown to produce GTP
from endogenous GDP in the mitochondria [82]. GTP was needed to
recycle AMP into ADP by the GTP–AMP kinase, which is also located in
the matrix [83]. Thus, in mitochondria, AMP generated by fatty acid or
amino acid activation (and because it has no access to extramitochon-
drial adenylate kinase) is stepwise and regenerated within the matrix
by GTP via ADP into ATP. Another GTP-regenerating reaction was
found in the intermembrane space that transferred phosphate from
ATP to GDP into GTP via the “NuDiKi” [83].
By consecutive steps of mitochondria extraction (i.e., using
osmotic shock for breaking the outer membrane, ionic strength for
desorbing inner membrane-attached enzymes, and sonication for
breaking the inner membrane for extracting enzymes from the
matrix space) of liver mitochondria, in the intermembrane space of
liver mitochondria adenylate kinase [84], and of muscle and brain
mitochondria, a new isoform of creatine kinase was found [85]. In
view of the dual location of creatine kinases both in mitochondria andin the cytosol, a creatine/creatine-P shuttle was proposed [12]. In the
intermembrane space ATP, this shuttle exports ATP from the matrix,
which transfers phosphate to creatine-P, which diffuses to the
cytosolic creatine kinase to transfer phosphate to ATP near the
myoﬁbrils. The shuttle has then been convincingly and extensively
documented with its structural and regulatory ramiﬁcations (e.g.,
[86]).
9. Membrane permeability
In the 1950s, electron microscopy had deﬁnitely shown that
mitochondria contain an outer membrane envelope and an intricate
inner membrane convolute. However, the function of these mem-
branes was not clear, and membranes did not play a role in
mitochondrial functions until the early 1960s. Plasma membranes
had a clear role of conﬁning the cytosol and solutes therein, and solute
transport was conﬁned to special openings, channels, pores, and
carriers. The erythrocyte was a prime target for elucidating how
solutes can be transported by carriers through a membrane. Their
membrane encloses a comparatively large space, facilitating transport
measurements. In contrast, mitochondria contain two barely discern-
able spaces squeezed between closely opposed membranes that do
not seem to require an obvious solute transport. On the other hand,
mitochondria were shown to be osmotically active by enlarging the
matrix space [87,88]. Several studies on the penetration of solutes into
mitochondria were reported [89,90], however, without clearly
establishing the barriers that are imposed by the external and internal
membranes. In collaboration with an electron microscopist and by
adapting the silicon-layer ﬁltration technique, Erich Pfaff undertook a
systematic study of permeability to the mitochondrial spaces
[84,91,92]. Besides with sucrose, the permeability of metabolites
such as aspartate, AMP, and NAD was used to measure the unspeciﬁc
rapid permeable space as compared to a slow speciﬁc permeable
space using 14C-labeled compounds and 3H2O. By changing the
osmolarity of the medium over a wide range and by estimating the
intramitochondrial spaces from the corresponding electron micro-
scopic images of differently structured mitochondria (liver and
kidney), a clear correlation of the “unspeciﬁc” space with the
intermembrane space was demonstrated. Using polyglucose, the
outer membrane was shown to be freely permeable to solutes up to
4000 MW, whereas the inner membrane constitutes a general barrier
for solutes to enter the matrix space.
10. Transport in mitochondria
10.1. General
With this background and the terra incognita of mitochondrial
metabolite transport, we decided to embark on directly measuring
transport into mitochondria. Technical challenges were the short
equilibrium time due to large membrane surrounding a small inner
volume that required high time resolution. The high metabolic
conversions of the transported substrates required rapid quenching.
The centrifugal silicon technique was reﬁned to contain multiple
layers for starting and stopping transport and quenching metabolism
[53]. The subsequent introduction of the inhibitor stop technique [93]
and the continuous further development of semiautomated or fully
automated rapid mixing and stopping machines [94] permitted to
measure transport kinetics to a resolution of 80 ms [95].
Initially, in the framework of our studies on substrate metabolism
in mitochondria (see above), we were interested in using the silicon
layer to measure the distribution of these metabolites in and outside
the mitochondria. One major ﬁnding was the energy-driven export
from mitochondria of aspartate formed from malate. We concluded
that mitochondria have an active aspartate transport [38] that was
later redeﬁned as an active glutamate/aspartate exchange [96].
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The presence of nucleotides in isolatedmitochondria and their role
in OxPhos [97–99] posed an obvious challenge to determine whether
these are bound, as mostly suggested, or conﬁned by an impermeable
membrane. Thus, in our program of systematically elucidating
transport in mitochondria and also on the background of our
phosphorylation studies [74,76], we paid special attention to the
transport of nucleotides. With the centrifugal silicon-layer ﬁltration
technique and 14C-sucrose/3H2O method to differentiate between
intermembrane and matrix space [90,92], we were able to clearly
segregate uptake into an immediate “unspeciﬁc” penetration and a
time-dependent “binding” of nucleotides [91],which was then
identiﬁed as an exchange between the “bound” and added nucleotides
across the matrix membrane. In contrast to the initial unspeciﬁc
permeation, the second-stage uptake was sustained only with ADP
and ATP. These results were reported in a symposium of the IUB
congress in New York in 1964 and discussed on the subsequent
famous and unconventional “compostium” at the farm of Lil and
Britton Chance, which united bioenergeticists from the East and the
West. When Bruni et al. [100] showed that atractyloside (ATR)
inhibited binding of ATP to mitochondria, it became immediately
clear [91] that ATR inhibited the already-discovered exchange of
ADP and ATP at the inner membrane and not the binding of ATP to
ATP synthase, as suggested by Bruni [101] and Bruni et al. [102].
Three other laboratories supported this ﬁnding by determining
that ATR inhibited only the phosphorylation of exogenous nucleo-
tides while oligomycin also of endogenous nucleotides. By acknowl-
edging our personal communication, it was concluded that ATR
inhibits the communication [103] or the transport between both pools
[104,105].
From this juncture, the elucidation of the transport of ADP and ATP
in mitochondria turned out to become a gold mine for understanding
transport and its regulation in mitochondria and for principles of
solute transport in general. The central role inmetabolism, channeling
the energy supply to the cell from mitochondria, paired with many
outstanding features conveyed a paradigmatic distinction on the
ADP/ATP transport. A few features to be mentioned are (1) very high
selectivity for the substrates [106], (2) the highly charged and very
hydrophilic nature of the large substrates, (3) the strong regulation by
high electrical forces of the mitochondrial membrane potential of the
highly charged substrates ADP3− and ATP4− [35,106], (4) the high
levels of the underlying carrier in mitochondria to cope with the high
demand for ATP in most aerobic cells, and (5) the unique existence of
highly speciﬁc inhibitors, as represented ﬁrst by ATR and then by
other atractylogenin glucosides, in particular by carboxyatractyloside
(CAT), greatly facilitating the characterization of the transport sites.
(6) To top this gift, nature provided another type inhibitor
represented by bongkrekic acid (BKA) [107–109]. This inhibitor
became a key to elucidating the transport mechanism of transport of
the ADP/ATP carrier (AAC) at the molecular level, being indeed the
ﬁrst time for any carrier [110]. (7) Stabilized by these inhibitors
toward detergents, in particular by CAT and thanks to its high levels in
heart mitochondria, the AAC protein became the ﬁrst carrier protein
to be isolated in the native state [111,112]. (8) With this protein, the
translocation mechanism was further elucidated and the involved
conformation changes were demonstrated [113,114]. (9) With the
isolated AAC, the ﬁrst rational reconstitution of a carrier into vesicles
was achieved, and the transport parameters were determined in
detail [115–117], in particular the differences between ADP and ATP
and the control by themembrane potential. (10) And lastly, with large
amounts of puriﬁed AAC available, in a major effort, the complete
primary structure was determined by amino acid sequencing [118].
Based on this experience and methodology, subsequently, amino acid
sequences were determined for the uncoupling protein [119] and
phosphate carrier [120]. The similarity of these sequences to that ofthe AAC led to the conclusion that the mitochondrial solute
transporters form a homologous family of proteins [120]. These
structures demonstrated that the sequence consists of three repeats
that were to become a hallmark feature of the mitochondrial carriers
[121]. On this basis, the transmembrane folding and the disposition of
residues to the membrane sides were probed with a battery of
chemical and physical methods. Finally, based on the stabilized AAC-
CAT complex, the three-dimensional structure of the AAC–CAT
complex was determined as the only crystal structure of any
mitochondrial carrier family member to date [122,123].
At nearly all these stages, the AAC provided a platform to deliver
the initial breakthrough in the ﬁeld of solute transport. Thus, the AAC
stands out as a paradigm not only for mitochondrial carriers but also
for many fundamental aspects of transport in general. Since, in a
recent detailed review devoted entirely to the AAC [81] we have laid
out the developments in this ﬁeld, no further details will be reported
here, and the reader is referred to this article.
10.3. Uncoupling protein
10.3.1. Isolation
The initial biochemical and physiological background of thermo-
genesis and uncoupling in brown adipose tissue (BAT) mitochondria
were reported in early reviews [124,125]. The developments, which
led to the identiﬁcation of the underlying protein, started with the
ﬁnding that GDP is an inhibitor of the uncoupling induced by fatty
acids in BAT mitochondria [126]. Rafael and Heldt [127] and Nicholls
[124] determined binding of GDP to the outer side of the inner
membrane of BAT mitochondria. In SPAGE of brown fat mitochondria,
Ricquier and Kader [128] reported a prominent 32-kDa band that
increased with cold adaptation, and Desautels et al. [129] correlated
this protein with the increase in GDP binding. Heaton et al. [130]
identiﬁed a protein band with MW= 32 kDa as a putative site for the
uncoupling by labeling with azido-ATP32. At this stage, they suggested
that the azido-ATP binding proteinmight function as a regulatory unit
for the actual uncoupling channel.
Given the similarity of MW between the AAC and the UCP1
protein, we assumed that UCP1 might also be isolated by the novel
methods that we had developed for the isolation of AAC in native state
[111,112,131], such as the pioneering use of nonionic detergents that
were largely in disfavor still in the early 1970s, and the separation of
the protein detergent micelles by hydroxyapaptite. A major problem
and effort was to procure a sufﬁcient supply of BAT mitochondria. By
modifying some details of the isolation procedure for the AAC, Qui-
Shui Lin succeeded in isolating the “nucleotide binding protein” from
BAT mitochondria, which we then baptized “uncoupling protein”
(UCP) [132,133]. Subsequently, others introduced the name “thermo-
genin” [134] that was to reﬂect the thermogenesis function. But
“uncoupling protein” persisted, and in hindsight, it is an appropriate
name as other UCPs (UCP 2 to 5) discovered later do not have a
thermogenetic but still retain an uncoupling function. Interestingly, in
contrast to AAC, UCP1 could be isolated in native yet fairly stable state
without stabilization by an inhibitory ligand, such as GTP, etc.
Similarly, to the AAC, UCP1 also formed dimers in the detergent
micelles, as found in hydrodynamic studies and by oxidative cross-
linking between SH groups in the C-terminal tail [135]. Also in
mitochondria, UCP1 exists as a dimer as shown by SH cross-linking.
10.3.2. Reconstitution
Although most research on UCP function and regulation relies on
mitochondria, we believe that by the reductionist approach, using
isolated UCP and reconstitution into lipid vesicles, the search for the
function of UCP1 is best served. To date, research results on
mitochondria have not been able to clarify the regulation of UCP1
and unequivocally the function of UCP2 to 5. In the reconstituted
system, unknown components cannot interfere and questions, such as
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Following our credo, to measure a function as directly as possible, we
measured for the ﬁrst time directly H+ transport by UCP1, using pH
electrode outside and pH probes inside the vesicles. Before, H+
transport was deduced in BAT mitochondria indirectly by swelling in
K+ acetate [136] or by respiration. Furthermore, we measured H+
transport in both directions, whereas by the acetate swelling, H+ is
transported opposite to the physiological uncoupling direction. H+
transport is limited by the H+ pumping of the respiratory chain and
does not permit true H+ transport. Also in mitochondria, uncoupling
is inﬂuenced by endogenous ATP, fatty acids, etc. The reconstituted
system gives freedom in the choice of the parameters and allows
measuring H+ transport in both directions. The reconstitution was
built on the methods developed with AAC [137] but required some
modiﬁcations for generating H+-tight proteoliposomes with an active
UCP1 [138,139]. Different detergents had to be chosen, and their
careful removal had to be optimized. Suitable buffer and K+ gradients
had to be built in for driving H+ translocation.
The reconstituted system clearly showed that three crucial
parameters control the H+ transport activity of UCP: (1) The H+
electrochemical gradient ΔμH+, in particular Δψ [138,139], (2)
activation by fatty acids (FA) [140,141], and (3) the inhibition by
nucleotide binding. UCP1 was thus proven to combine the H+-phoric
with the regulatory- activating and -inhibiting functions in one
protein, at variance with the previous suggestion [130]. Although the
basic controlling factors were principally known from mitochondria,
the characteristics of these dependencies were quite different with
the isolated UCP1. On further scrutinizing the research conducted on
mitochondria, the dependence of uncoupling on FA and the inhibition
by nucleotides became increasingly blurred, culminating in denying a
regulatory effect of FA and nucleotides on the uncoupling by UCP in
vivo [142–144].
10.3.3. The inﬂuence of membrane potential and activation by fatty acids
As to be expected for the uncoupling function, UCP1-catalysed H+
transport is driven by Δψ in the reconstituted system. Of great
signiﬁcance was the ﬁnding that the H+ transport rate (H+-
“conductivity”), activated by FA and inhibited by nucleotides, was
linearly dependent on Δψ generated over a wide range by the K+
diffusion potential [138]. This may seem trivial, but it differed from
the non-ohmic H+ conductivity observed in mitochondria [145] at
higher Δψ and from the logarithmic relation to Δψ observed for the
ADP/ATP exchange.
The dependency of uncoupling in BAT mitochondria on long-chain
FA was only detected after endogenous FAs were removed by bovine
serum albumin (BSA) [146]. Similarly, with reconstituted UCP1, a
requirement for FA was shown only after treatment with BSA [141]. In
this context, only the GDP-sensitive stimulation of H+ transport by FA
was attributed to UCP1. The orientation of the UCP1 protein in the
vesicles must also to be accounted for being mostly right side out
[139]. Under these conditions, UCP1 activity exhibited a near-total
dependency on FA.
The structural requirements are generous for FA are generous
[141,147–149]: a minimum chain length of C-8, both saturated and
unsaturated and substitutions at various positions of the hydrophilic
group includingω-position, such us Br-, OH-, azido-, doxyl-, carboxyl-
and of large hydrophobic groups such as phenyl- are tolerated.
Furthermore, rather high amounts of FA, amounting up to several
percentages of lipid vesicle mass, are required for maximum activity
[141]. This speciﬁcity laxity may indicate that there is no well-
structured binding site for FA but that FA may be located with their
hydrophobic part at the protein–membrane interface, whereas the
carboxyl may enter a hydrophilic niche in the UCP1. These aspects are
important for the mechanism of FA-stimulated H+ transport. Two
models are discussed, FA transport cycle, where analogous to the
classic uncouplers. FA-anions are driven through the membrane andundissociated FAH returns by diffusion [150–152]. The rate-limiting
and slow FA-anion switching is accelerated by UCP1 transporting the
FA-anion. In the other model, UCP1 functions as a H+ transporter
with a channel for H+ in which FA provides with its carboxyl an
essential H+ buffering or transferring group [141,147,149]. Further
results (see below) [142,144,153,154], indicating that UCP1 can
uncouplewithout FA, are readily reconciledwith a direct H+ transport
mechanism that is enhanced by FA buffering.
Although most of the evidence for an essential role of FA comes
from the reconstituted systems, there have been reservations about
an obligatory function of FA in BAT mitochondria, implicating H+
transport without FA [142,145,155]. It has been suggested, however,
that instead acyl-CoA may activate UCP1 [140,156]. Others concluded
[157] that the role of FA is to overcome inhibition by nucleotides only
at higher ΔμH+, in a range where the H+ conductance increases
nonlinearly with Δψ.
In contrast, on examining the FA requirement of UCP1 expressed in
yeast, it was concluded that, at high ΔμH+, the uncoupling is not
dependent on FA, whereas at low ΔμH+, FA are required as in
the reconstituted system [142]. As compared to mitochondria from
UCP−/− mice, in UCP+/+ mitochondria, the basal uncoupling was
higher and could be speciﬁcally inhibited by GDP [154]. FA could
strongly stimulate uncoupling despite the presence of GDP. By using
pyruvate instead of G1P as a substrate, the mutual inﬂuence of FA and
GDP on the UCP1+/+ versus UCP1−/− mitochondria was reex-
amined [144] and a competition between FA and GDP on the
uncoupling activity was shown. However, the GDP concentration
required was up to 50 times higher than in vesicles. A competition
between FA and nucleotides had not been observed in the
reconstituted system, either for uncoupling activity or for the binding
of GDP [141]. Only with less tightly binding DANS–GTP that a small
competitive removal of the nucleotide was observed [158].
Since it was shown that UCP1 has a basal uncoupling activity
without FA, which appears to be missing during reconstitution of the
isolated UCP1, it was suggested [159] that an additional activator,
existing in mitochondria, is lost upon isolation of UCP1. For example,
retinoic acid [160,161], coenzyme Q [162], superoxide [163], or
hydroxyl-nonenal [164] had been reported to function as activators.
However, all of these cofactors had been contested, see [144]. So the
question as to the existence of another cofactor besides FA is still
unresolved. A new proposal as to why UCP1 responds so differently to
FA will be discussed in chapter 10.3.7.
10.3.4. The binding of nucleotides and inhibition of H+ transport
The inhibition of uncoupling, i.e., of H+ transport by nucleotides
has been a hallmark of UCP1-speciﬁc activity. As discussed above,
the binding of nucleotide was instrumental for discovering and
isolating UCP1. This binding is distinguished by peculiarities with
important functional implications that may be illustrated by
comparing with the nucleotide binding to the AAC [165]: In both
AAC and UCP1, the “free” forms ADP3− and ATP4− are bound
[133,166]. In UCP1, binding speciﬁcity is less stringent as other
purine nucleotides GDP and GTP and ﬂuorescent derivatives are
bound [149,167,168]. In UCP1, the nucleotides inhibit H+ transport,
whereas in AAC, ADP and ATP activate their own transport. In UCP1,
nucleotides bind only from the c-side, whereas in AAC, they bind
from both sides of the protein. Concomitantly, nucleotide binding
stabilizes UCP1 [169,170] but destabilizes AAC protein [131,171].
The binding afﬁnity is high in UCP1 [167] and low in the AAC [172].
Nucleotide binding in UCP1 is strongly pH-dependent [167] but is
little inﬂuenced by pH in AAC.
The pH dependence of nucleotide binding attracted our special
attention. It was ﬁrst noticed in mitochondria [124], and later, the
binding was measured by various methods in great detail with
isolated UCP1 [133,167,173]. In general, the binding afﬁnity decreased
with increasing pH. With GDP and ADP, single break points in the
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slope changed from −0.1 to −1.2. With GTP and ATP, two break
points were observed where the pKD/pH slopes increased from−0.1
to −1 at a pH of about 6.5 and then to −2 at pH 7.3. Thus, with
increasing pH, the afﬁnity decreases drastically with A(G)TP,
amounting to a nearly 100-fold afﬁnity decrease at pH 7.5. Based on
a model, in which the pH proﬁles reﬂect an interplay of H+
dissociation at the nucleotide phosphates and two constituent H+-
dissociating residues in UCP1, equations were set up for the KD–pH
relations. The observed curves were successfully ﬁtted with curves
calculated with the equations by inserting pK=6.5 for the nucleotide
and pK=3.8 and 7.2 for the two dissociating groups in UCP1, thus
conﬁrming the complex binding–pH model [166]. These results also
implied that NDPH2− and NTPH3− bind much more weakly than the
fully dissociated NDP3− and NTP4−. The addition of Mg2+ shifted the
pKD/pH proﬁle in the same manner as predicted by assuming that the
Mg2+ nucleotide complexes do not bind.
The mechanistic interpretation of pH dependence [167] involves a
H+ binding with a pK of 3.5 to an Asp- or Glu-carboxyl group. The
additional binding of a H+ with a pK of 7.3, assumed at a His, is
necessary only for NTP binding. These predictions could be elegantly
substantiated in isolated UCP1 by the identiﬁcation of one Glu residue
(E190) exhibiting a unique reactivity to the Woodward carboxyl
reagent [174]. Only two molecules, reagent/UCP1, sufﬁced to block
nucleotide binding. The residue could be identiﬁed as E190 by UCP1
fragmentation and sequencing [174]. Also chemically, the second
dissociation group was identiﬁed as H214 [175]. Later mutagenesis of
E190 [176] and H214 [175] into neutral residues showed that these
groups were involved in nucleotide binding. As predicted, blockage or
mutation of H214 only impaired NTP but not NDP binding.
These results were rationalized [177] in a model (Fig. 5) in which
access to the binding niche for the phosphate moiety of the
nucleotides is controlled by H+ dissociation at critical residues. At
the entrance to the binding cavity, E190 as a gatekeeper blocks accessFig. 5. Mechanism of pH control of nucleotide binding to UCP1. Addition of H+ to E190 o
nucleotides. A second H+ addition converts H214 at the bottom of the binding cavity into th
cavity thus making room for the γ- phosphate of ATP or GTP, while ADP or GDP can bind aby building a salt bridge with a basic residue. On adding a H+, E190
relaxes the salt bridge and the gate opens to admit NDP and NTP.
Importantly, only the dissociated forms NDP3− and NTP4− bind well
forming two or three salt bridges or hydrogen bonds (not shown). At
the bottom of the cavity, H214 controls binding of NTP4− by
protruding into the space reserved for the γ-phosphate of NTP4−.
The protonized HisH+ is suggested to form a salt bridge with negative
background charges, identiﬁed as D209 and D210 by mutagenesis,
and thus allow docking of the γ-phosphate. In both cases, the pH-
induced rearrangements of salt bridges control nucleotide binding.
10.3.5. Masking and unmasking of nucleotide binding
The masking–unmasking phenomenon of nucleotide binding to
BAT mitochondria may offer a window for the in vivo regulation of
UCP1. Several groups reported that, for example, in BAT mitochondria
from rats housed at 27 °C, the amount of GDP binding could be
increased twofold on short-term exposure (20 min) of the rats at 4 °C
[178–182]. Obviously, binding sites were unmasked by the cold
exposure. Different explanations were offered, such as conformation
changes [182,183] or exposure of binding sites by swelling [180]. In a
detailed work, we could show [184] that the masking is caused by
endogenous ATP tightly bound to UCP1, thus blocking the binding of
added GDP. Based on the strong pH dependency of ATP binding, we
treated the warm-adapted BAT mitochondria with Dowex at high pH
(8.0) to remove the masking ATP and thus strongly increased binding
of added 3H-GTP. Conversely, up to 90%masking could be produced by
exposing cold-adapted BAT mitochondria to ATP at low pH. After
washing the mitochondria, ATP clings to UCP1 because of its very
slow dissociation rate, whereas ADP dissociates faster (see below).
Thus, the masking effect does not reﬂect a conformational change
but indicates to what degree UCP1 in vivo is blocked and/or
unblocked when thermogenesis is triggered by cold exposure. The
results are a strong argument that ATP binding and unbinding are
involved in the regulation of the uncoupling activity in vivo. Aspens a salt bridge at the entrance of the binding cavity for the phosphate moiety of
e charged form HisH+ which, by forming a salt bridge with E209, is retracted from the
lso when H214 is neutral (modiﬁed Fig. 6 in [149]).
Fig. 6. Two-stage, loose and tight modes of nucleotide binding. Correlation between
tight binding and inhibition of transport. The distribution between tight (U*N) and
loose (UN) UCP1 nucleotide complex KC=U*N/UN is measured by the resistance to
proteolysis: the loose complex is readily degraded, whereas the tight complex is slowly
degraded by trypsin. Various degrees of tight binding generated with ﬂuorescent DAN–
and DANS–nucleotide derivatives (Fig. 7 in [173]).
588 M. Klingenberg / Biochimica et Biophysica Acta 1797 (2010) 579–594elucidated below, the release of ATP from UCP1 upon cold exposure
may depend on the increase of CL adjacent to UCP1 caused by FA
release.
10.3.6. Fluorescent nucleotide derivatives—two-stage binding
Fluorescent derivatives of the nucleotides substituted with DAN
(dimethylamino-naphthoyl) and DANS (dimethylamino-naphtha-
lene-sulfonyl) provided a very fruitful platform to analyze the
intricacies of nucleotide binding [173,185,186]. In general, the DANS
derivatives had a higher afﬁnity than the DAN nucleotides. The
afﬁnities increased from DANS–AMP, –ADP, –ATP to –GTP, and each
derivative surpassed the afﬁnity of their parent nucleotides. By
competition with these ﬂuorescent probes, the binding of a larger
range of other nucleotide derivatives, the inﬂuence of ions, and amino
acid reagents could be conveniently measured [185].
A discrepancy was noted between binding signaled by ﬂuores-
cence and binding of the labeled compounds using a Dowex ﬁltration
method, whichmeasured a lower binding for some derivatives [173].
This difference was large with DANS–AMP and the DAN–derivatives
and lowest with DANS–GTP. Obviously, a portion of the DANS–
nucleotides bound to UCP1 was removed by Dowex because of a
weaker binding afﬁnity. It was concluded that these derivatives
exhibit a two-stage loose and tight binding. Most interestingly, this
two-stage binding was also reﬂected in the inhibition of H+
transport. The inhibition by the DANS derivatives reached only 9%
to 88% of the parent nucleotides, approximately correlating to the
tight versus “loose” binding. Thus, for example, binding of 0.1 mM
noninhibiting DANS–AMP could reverse inhibition by 10 μMATP. The
pH proﬁle of the inhibition is also different from the total binding as
monitored by the ﬂuorescence. A third parameter demonstrating the
two-stage binding is the stability of the isolated UCP1 towards
proteolysis [173]. DANS–nucleotides were less effective in protecting
against limited digestion by trypsin than the parent nucleotides. The
protection was nearly equally strong with DANS–GTP as with GTP,
whereas DANS–ATP conferred only about 50% and DAN–ATP
conferred nearly no protection. The capability to protect approxi-
mately paralleled the extent of H+ transport inhibition by the DANS–
and DAN–nucleotides.
The kinetics of binding and dissociation further supported the
two-stage binding evidence [186]. It had been noted earlier that the
binding rate of nucleotides to UCP1 is unusually slow [167]. The
slow phase is preceded by an initial fast binding phase, which could
be resolved only with rapid ﬂow mixing and ﬂuorescence recording
of DANS–nucleotides [185]. The binding kinetics of normal nucleo-
tides was measured using an automated sampling and ﬁltering
method that resolved only the second slow binding phase, which
could last up to 250 min for 90% completion at higher pH [186].
Binding and dissociation rates of ADP and GDP were much higher
than those of ATP and GTP. By displacing DANS–ADP upon addition
of GTP, the slow transition into more tight binding could be
followed by the ﬂuorescence decrease. This kinetics could be well
ﬁtted with the rate equations set up for UCP1 to adopt two
consecutive binding states with different binding afﬁnities and
rate constants for the binding and dissociation [186]. The results
show that the loose binding states revealed by the derivatives are
also the initial binding states for the nucleotides proper, which,
depending on the derivative, can be transited more or less rapidly
into the tight state.
To some extent, the two-stage binding may be compared to the
“induced transition ﬁt” (ITF) of nucleotide interaction with the AAC
[187]. Initially, ADP or ATP binds with a poor ﬁt in the ground state of
the AAC. From here, ADP or ATP induces a change of the binding site
into the transition state, driven by the energy of the better ﬁt of the
transition state. Substituted ADP, e.g., DAN–ADP remains stuck in the
ground state. However, different from UCP1, the transition state of
AAC with ADP is labile as discussed below.The two- stage binding can be formulated in the simplest terms,






U is the relaxed and U* the tight, inhibited state of UCP1. KC is the
distribution constant of the loose versus tight binding state and is
related to the fraction of tight to total complex KC/1+KC. The share
of tight UCP1 nucleotide complex evaluated from the above
described three types of evidence agreed fairly well and ranged
from 95% to 2% with the ﬁve DANS– and DAN–nucleotides tested, and
100% for the nucleotides proper. In Fig. 6, the tight/loose binding
distribution of UCP1 as determined from trypsin resistance plotted
against the inhibition of H+transport yielded a fairly good correla-
tion. This showed that UCP1 assumes the inhibited state only when
the nucleotide is able to induce important conformation changes
into a more rigid structure as reﬂected in the trypsin resistance.
Conversely, this indicates that the H+ transport activity requires
ﬂexibility of the UCP1, as in a gated transport mechanism but not in a
channel-type transport.
The two-stage binding in conjunctionwith the inﬂuence of the two
H+ dissociating groups at the binding pocket and the H+ dissociation
of the nucleotide phosphate allows to draw a more complete picture
of the ﬂexible nucleotide binding (right-hand side of the scheme in
Fig. 5) [148]. The phosphate binding in the pocket is tightened by ionic
forces between the phosphates and by positively charged arginines
(see below). These local changes are part of larger rearrangements
that conceivably have to surmount high-energy barriers and therefore
can be slow. In this realm, it is noteworthy that with A(G)TP the
transition is much slower than with A(G)DP [186]. An extra slow
accommodation of the γ-phosphate of A(G)TP by “pushing back”
H214 may be the reason for the slow transition to the tight state.
10.3.7. Cardiolipin and regulation of UCP1
Upon reconstitution of UCP1, we obtained the highest H+
transport rates and high afﬁnity of nucleotide binding and parallel
inhibition by using puriﬁed egg yolk phospholipids (PL) [139].
Interestingly, admixture of cardiolipin (CL) to the lipids strongly
decreased binding afﬁnity of nucleotides measured with 14C-GTP and
-ATP [188]. Correspondingly, the inhibition of the FA activated H+
transport became less sensitive to nucleotides. The half effective
“concentration” of CL in releasing the bound ATP was 4% CL by weight
of total PL (M. Klingenberg, unpublished data). The isolated UCP1
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bound CL, as compared to isolated AAC which has 3 tightly bound CL
per monomer AAC [189]. The lack of bound CL is in accordance with
the tight nucleotide binding in the PC vesicles.
These results seem to be at odds with the observation that in
mitochondria with a high CL content of about 15% CL by weight of
total PL [190] the afﬁnity of nucleotides for UCP1 is only slightly lower
than in the reconstituted vesicles. A considerable part of an estimated
up to 20% of total CL is bound to membrane proteins [191–194] but a
larger part may be concentrated in particular domains [195] so that
“free” CL available to UCP1 may be low. It is speculated that the level
of “free” CL and conversely the domain-bound CL varies under
different metabolic conditions [196].
In BAT in the warm-adapted state, UCP1 has a high afﬁnity for ATP
as reﬂected in the masking phenomenon [184], indicating low CL
levels surrounding UCP1. Upon cold exposure, as themitochondria are
ﬂooded with FA, ATP is apparently released from UCP1. However, FA
cannot directly remove ATP from UCP1 since FA does not compete
with bound nucleotides—as shown in the reconstituted system. Here,
we propose that the high levels of FA accumulated in the inner
membrane (probably N5 mol%) disturb the high CL content domains
and thus release “free” CL that can diffuse to the UCP1 environment.
When CL reaches a level of at least 3–4% around UCP1, the binding of
ATP is relaxed and FA can now activate H+ transport. Thus, FA
interacts at two levels, releasing CL and activating UCP1. A pH increase
in the intermembrane space and/or locally around UCP1 may also
contribute to the release of ATP. Here, CL may have a role by providing
the local H+ acceptor for raising the pH [197,198]. We can thus
rationalize all the elements for the regulation of UCP1 elaborated in
the reconstituted system in vivo such as inhibition by nucleotides in
the tight binding state, the strong pH dependency of binding, the
absolute requirement of FA for the activation of UCP1, and the relief of
nucleotide binding by CL. Variable CL distribution would mediate the
regulation of UCP1 by changing the KD of nucleotide binding. In thisFig. 7. The regulation of UCP1 by nucleotides and fatty acids (FA). (A) Binding of nucleotides
whereas the transition to the tight state is slow. FA binding is independent of nucleotide b
mediation by cardiolipin (CL). CL binding to UCP1 releases nucleotide binding. FA induces th
interactions starting with the release FA by cold stimulation, the subsequent release of CL,perspective, CL may represent the activator postulated by Matthias et
al. [143]. The inﬂuence of CL may also partially explain the
discrepancies of the GDP sensitivity of UCPs reconstituted without
CL (Winkler et al. [141]) andwith 8% CL of the vesicle PL (Jaburek et al.
[199]).
Our view of the inﬂuence of nucleotides and FA on UCP1 is
schematically summarized in Fig. 7. The nucleotide binding stages of
UCP and the role of FA, based on the data of the reconstituted CL-free
system, are illustrated in Fig. 7A. It is conceded that UCP1 alone may
have a low basic uncoupling activity but that FA conveys a much
higher uncoupling activity on UCP1. In the tight binding state, U*N
nucleotides inhibit and FA can activate UCP only in the loose binding
state (UNF) but cannot activate UCP in the U*NF complex. FA binds
independently of nucleotides, and there is no direct competition
between nucleotides and FA [141]. In Fig. 7B, the binding scheme
includes the interference of CL with the nucleotide and FA interactions
with UCP1. These binding steps schematically represent the regula-
tion of UCP1 inmitochondria and in vivo, as they are elucidated above.
The apparent discrepancies for the FA requirements may be
reconciled by pointing out that the uncoupling in mitochondria
implies much lower H+ transport rates than those measured in
proteoliposomes. Thus, a basic uncoupling rate without FA in
mitochondria would amount to only a few percentages of total FA-
dependent uncoupling in vesicles. According to this view, UCP1 alone
is assumed to possess a basic H+ transport activity that may, however,
have a low physiological signiﬁcance. Another discrepancy to be
explained is the apparent competition between FA and nucleotides on
the uncoupling activity in mitochondria versus no competition in
proteoliposomes. The intervention of CL may at least partially resolve
this conundrum: FAs accumulating in the membrane are visualized to
disturb CL domains in mitochondria thus rendering more CL to the PL
shell surrounding UCP1. CL strongly decreases the afﬁnity of
nucleotides in addition to inducing a local pH increase that, in
particular, affects binding of the physiological ligand ATP.has two stages: ﬁrst, a loose state followed by the tight state. The initial binding is fast,
inding. FA strongly enhances uncoupling activity. (B) Regulation of UCP1 activity with
e release of CL from CL domains (Cbound), allowing CL to access UCP1. The sequence of
the binding of CL to UCP1, and the release of nucleotide are indicated by red arrows.
Fig. 8. Role of UCP3 as a facilitator of fatty acid oxidation. Fatty acid oxidation is limited
by the availability of NAD for the β-HO-acyl-CoA dehydrogenation, which has a higher
mid-redox potential than NAD. Due to reversed electron transport from the acyl-CoA
dehydrogenation (red arrows) NAD is largely reduced and the low NAD level limits the
cycle. Partial uncoupling by UCP3 decreases ΔμH+ and reversed electron transport thus
increases the NAD level, facilitating the β-HO-acyl-CoA dehydrogenation and
consequently FA oxidation.
590 M. Klingenberg / Biochimica et Biophysica Acta 1797 (2010) 579–59410.3.8. Identiﬁcation of essential residues
For the mutagenesis of targeted residues, UCP1 was expressed in
Saccharomyces cerevisiae where it readily incorporated in mitochon-
dria [176,200,201]. In hindsight, this was surprising since expression
of the isoforms UCP2 and 3 resulted in an inactive protein [202,203],
which is apparently deposited in a type of late Golgi-type inclusion
bodies that cannot be solubilized by nonionic detergents. The fact that
yeast expressing UCP1 grew fairly well on nonfermentative sources
but that expression of UCP2 and 3 strongly retarded growth even on
fermentative sources [202] indicated that traces of UCP2 and 3
initially inserted intomitochondria uncoupled and thus prevented the
proper energy-dependent incorporation of the bulk of the expressed
UCP [203]. This implies the assumption that, in yeast, UCP1 is
inhibited by ATP, whereas UCP2 and 3 are not. This difference ﬁnds its
correspondence in opposite response to nucleotides in reconstituted
vesicles, where UCP1 is strongly inhibited by an increasing ATP/ADP
ratio and UCP3 conversely by a higher ADP/ATP ratio [204].
The effects of the mutations were checked with the isolated yeast
mitochondria and the isolated reconstituted protein. The predicted
role of E190 as conferring pH dependency by gating the putative
phosphate-binding cleft was substantiated [176]. Moreover, the
special role of H214 in controlling binding of ATP(GTP) but not ADP
(GDP) was clearly demonstrated [175]. Thus, the mechanism of pH
regulation of nucleotide binding (see Fig. 5) seemed well established.
E190 and H214 are conserved in all 5 mammalian UCPs despite the
minimum 25% sequence similarity, indicating a similar pH control
mechanism in the other UCPs, as elaborated for UCP1. Given that these
mutations did not affect H+ transport per se, other conspicuous
residues seemed essential for H+ transport. D27 in the ﬁrst helix is
conserved in all UCPs and is located at the homologous position of the
essential K22 in AAC [205]. In D27N, H+ transport is abolished, but Cl−
transport remains unaffected. There is no effect on nucleotide binding,
conﬁrming that the sites for H+ transport and nucleotides do not
overlap. A pair of His present exclusively in UCP1 also seemed to be
involved in H+ transport [206].Three arginines, R83, R182, and R276,
located at equivalent positions in the even-numbered helices of the
three repeat domains, were shown to participate in nucleotide
binding. R83 was also important for Cl− transport. D210 and D209
were shown to be involved in the pH control of GTP binding
presumably by forming a pH-dependent salt bridge with H214
[207]. Furthermore, D210 may be involved in H+ transport at the c-
side and D27 at the center of UCP1. E167was shown to be essential for
Cl− but not H+ transport, indicating that Cl− and H+ or the respective
FA anion may not use the Cl− path, arguing against the FA cycle
mechanism. To better understand their role, the tentative position of
these residues might be visualized in a simulated three-dimensional
structure of UCP1 simulates from the AAC crystal structure.
10.3.9. UCP3 as a facilitator of FA oxidation
The role and mechanism of UCP3 like that of the other UCP1
homologues have been intensively studies (recent reviews [208–
211]) and will not be discussed here. An often overlooked funda-
mental difference to UCP1, even in those organs that contain
maximum levels of UCP homologues, is that the expression level of
UCP2 and 3 is up to 1000 times lower than that of UCP1 in BAT,
reminding that these homologues can exert only subtle effects, and
their deﬁciency is not deleterious to those organs. UCP3 and other
homologues have been implicated, apart from reactive oxygen species
(ROS) suppression by uncoupling, in the transport of O2− , FA
peroxides, or FAs. Since UCP3 expression in skeletal muscle is
stimulated by exercise [212–214] or starvation [215], a role for
UCP3 in FA oxidation as an FA transporter or suppressant of ROS was
suggested.
Here we wish to propose an intervention by UCP3 in FA oxidation,
based on the function as uncoupler. In the β-oxidation of FA, two
dehydrogenation steps occur in synchrony: oxidation of acyl-CoAwithFAD as hydrogen acceptor and of β-hydroxy-acyl-CoAwith NAD as the
hydrogen acceptor (Fig. 8). In isolated mitochondria, FA as a substrate
causes a nearly as high reduction of NAD as succinate (Fig. 13 in [66]),
higher than other NAD-linked substrates. It was concluded that the
oxidation of FA similar to that of succinate ensues reversed electron
transfer from the FAD-linked acyl-CoAdehydrogenation toNAD.ΔμH+
drives electrons fromCoQvia Complex I to NAD, enhancing theNADH/
NAD ratio. Thus, the NAD system assumes a too negative redox poten-
tial in comparison to that needed for the efﬁcient dehydrogenation of
β-HO-acyl-CoA, and this step becomes severely rate-limiting for the FA
oxidation. Acting as a relief valve, UCP3 lowers ΔμH+ by slight
uncoupling, thus alleviating this backup and enabling a higher FA
oxidation rate as needed under high workload in muscle. Apart from
this ΔμH+ valve, there is a “hydrogen relief valve” provided by the
ketogenesis with the reduction of acetoacetate to hydroxybutyrate. To
what degree the two valves facilitate FA oxidation would depend on
the ketogenesis potential of the organ. In contrast to UCP1 in BAT,
wherenearly all oxidation energy is converted into heat, UCP3only has
to partially uncouple so that most of the oxidation energy is still
converted into ATP. Correspondingly, the level of UCP3 is much lower
than that of UCP1 in their respective tissues.
11. Induced transition ﬁt of transport catalysis
For some time, my attention has been concentrated on the
energetic mechanisms in transport, in particular on carrier catalysis.
Some results in our studies on the mechanism of AAC transport
required a fresh look to comprehend the substrate–protein interac-
tions during the translocation process. Thus, a general concept of
carriers catalysis evolved [216], named “induced transition ﬁt ” (ITF)
[187]. Recently, we published several papers further elucidating the
ITF and its consequences and applications [216–218].
The single binding center-gated pore mechanism (SBCGP) as
elucidated with the AAC [171,217] served as a springboard for the ITF
concept. “Odd” results with the AAC challenged the classic wisdom on
catalytic processes and substrate–protein interaction. For example, it
seemed a paradox that the highly selective substrates ADP and ATP
bind weakly to the AAC, whereas some nontransportable nucleotide
analogues bind more tightly. Also, ADP and ATP destabilize the AAC,
whereas inhibitors stabilize the structure. During the translocation
steps, in carriers, the protein assumes global conformation changes, as
noted earlier with the AAC [217]. These changes are necessary for the
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In the AAC, these conformation changes are expected to be especially
large due to their bulky substrates.
The essential tenets of the ITF in brief are as follows: in the two (in
and out) ground states of the carrier, the binding site does not ﬁt the
substrate well, but the initial binding energy is sufﬁcient to loosen the
carrier structure and induce the transition state in which the binding
site assumes a conformation to optimally engulf the substrate. The
gradient from the initial intrinsic weak-to-strong binding is the force
for driving the AAC into the transition state. It provides the “catalytic”
energy necessary for the large conformation energies. As a result, the
net apparent binding energy, i.e., the intrinsic binding energy minus
the conformation change energy, is low. In enzymes, the binding site
has a preformed conformation to which the substrate ﬁts only after
being deformed into the transition state, whereas in a carrier, the
substrate induces the transition state from the ground states and the
binding center is changed to an optimum ﬁt for the substrate. In a
nutshell, opposite to enzymes, in carriers, substrates function as
catalysts for the protein structure rearrangements.
By deﬁning the energetic constraints for transport catalysis, the ITF
determines a variety of parameters for the working of carriers and
generating a number of rules and predictions. One obvious rule is the
intrinsic advantage of exchange, where both the forward and the
return branches proﬁt from substrate binding energy. In unidirec-
tional transport systems, the return step has to surmount the
activation barrier of conformation changes without relying on binding
energy and thus becomes the rate-limiting step. Thus, unidirectional
transport should be conﬁned to small substrates that require small
conformation changes. Further, the conformational rearrangements
may be smaller and/or involve weaker bonds in unidirectional
transport than in exchange transport.
All these rules apply to unassisted carriers and are exempliﬁed in
members of the mitochondrial carrier family. When the conditions of
the ITF cannot be fulﬁlled, external energy may supply additional
catalytic energy by cation cotransport or by ATP. So far, “active”
transport implied that energy is invested exclusively into uphill
gradients. From the perspective of the ITF, energy input has to be
reinterpreted to also furnish to a varying extent catalytic energy. In
fact, the restrictions of the ITF would exclude the majority of
unidirectional transport required by cells unless catalysis is assisted
by external energy.
A case can be made for the multiple drug-resistant Pgp, which is a
prominent member of the ABC transporter superfamily [218].
Although it is often called a pump [219], there is quasi no uphill
transport, but the large substrates may require large conformational
changes in the Pgp. On the other hand, structural largess of the
transported hydrophobic substrates indicates weak intrinsic binding
energy. The catalytic energy deﬁcit may be compensated by ATP. In
accordance with the ITF, hydrolysis of ATP is shown to be associated
with the return step, at variance to the view that the “power stroke” of
ATP drives substrate translocation.
Another implication of the ITF concerns inhibitors of transport.
Well-ﬁtting ligands to the ground states cannot be transported and
may even inhibit transport, blocking theweakly binding transportable
substrates. Since carriers expose two opposite faces of the binding
center, there potentially exist two different groups of transport
inhibitors matching the “in” and “out” ground states. In contrast, in
enzymes, inhibitors may match the transition state.
12. Conclusions
Having participated in bioenergetics in the last 55 years, my
science stations have been part of a wide range of developments from
the functional characterization of the respiratory and oxidative
phosphorylation system, the energy-transducing organelles to the
identiﬁcation of the components, their structure, and mechanism.Membrane proteins and membranes are at the center stage of
bioenergetics. Their molecular characterization has been slow in the
beginning, but with advanced technology, it is experiencing an
increasingly accelerating progress. In the future, physics will still be
more dominant in unravelling the details of the mechanisms.
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